New Immunological Markers of Thromboembolic and Hemorrhagic Complications after Coronary Artery Bypass Grafting. Asian Journal of Pharmaceutics (AJP), [S. l.], v. 11, n. 04, 2017. DOI: 10.22377/ajp.v11i04.1734. Disponível em: http://www.asiapharmaceutics.info/index.php/ajp/article/view/1734. Acesso em: 15 apr. 2026.